Inventor · disambiguated record
Tangsheng Yi
Also filed as: YI TANGSHENG
5 granted patents·5 pending applications·10 citations·filing 2018–2024
73Inventor score
Top patents by PatentIndex Score
10 records- 0192US10752703B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2019·Granted Aug 25, 2020·7 cites·28 claims
- 0285US10738131B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2018·Granted Aug 11, 2020·2 cites·45 claims
- 0383US11939396B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2020·Granted Mar 26, 2024·1 cites·33 claims
- 0482US2024368306A1Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 0578US12312415B2Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of useGENENTECH INC·Filed 2023·Granted May 27, 2025·0 cites·48 claims
- 0666US2023416825A1Use of klk5 antagonists for the treatment of a diseaseGENENTECH INC·Filed 2023·Application pending·0 cites
- 0764US2025228864A1Therapies for the treatment of inflammatory bowel diseaseGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 0862US12312414B2Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of useGENENTECH INC·Filed 2020·Granted May 27, 2025·0 cites·49 claims
- 0958US2024084042A1Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies, and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 1042US2019078160A1Use of klk5 antagonists for treatment of a diseaseGENENTECH INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tangsheng Yi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →